SG10201606939WA - Composition for regulating blood sugar - Google Patents

Composition for regulating blood sugar

Info

Publication number
SG10201606939WA
SG10201606939WA SG10201606939WA SG10201606939WA SG10201606939WA SG 10201606939W A SG10201606939W A SG 10201606939WA SG 10201606939W A SG10201606939W A SG 10201606939WA SG 10201606939W A SG10201606939W A SG 10201606939WA SG 10201606939W A SG10201606939W A SG 10201606939WA
Authority
SG
Singapore
Prior art keywords
composition
blood sugar
regulating blood
regulating
sugar
Prior art date
Application number
SG10201606939WA
Inventor
Tzu-Ming Pan
Chun-Lin Lee
Ya-Wen Hsu
Original Assignee
Sunway Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sunway Biotech Co Ltd filed Critical Sunway Biotech Co Ltd
Publication of SG10201606939WA publication Critical patent/SG10201606939WA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/062Ascomycota
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/894Dioscoreaceae (Yam family)
    • A61K36/8945Dioscorea, e.g. yam, Chinese yam or water yam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/19Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
SG10201606939WA 2015-11-13 2016-08-19 Composition for regulating blood sugar SG10201606939WA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW104137535A TWI643616B (en) 2015-11-13 2015-11-13 Use of monascus fermented product and secondary metabolites thereof in manufacture of composition for regulating blood sugar

Publications (1)

Publication Number Publication Date
SG10201606939WA true SG10201606939WA (en) 2017-06-29

Family

ID=56851448

Family Applications (1)

Application Number Title Priority Date Filing Date
SG10201606939WA SG10201606939WA (en) 2015-11-13 2016-08-19 Composition for regulating blood sugar

Country Status (8)

Country Link
US (2) US20170135983A1 (en)
EP (1) EP3167894A1 (en)
JP (1) JP2017088593A (en)
KR (1) KR20170056419A (en)
AU (1) AU2016225884A1 (en)
CA (1) CA2939456A1 (en)
SG (1) SG10201606939WA (en)
TW (1) TWI643616B (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006296251A (en) * 2005-04-19 2006-11-02 Gunze Ltd alpha-GLUCOSIDASE INHIBITOR
TWI350733B (en) * 2009-04-24 2011-10-21 Sunway Biotech Co Ltd A method for manufacturing a red mold dioscorea
TW201038205A (en) * 2009-04-29 2010-11-01 Sunway Biotech Co Ltd The compositions of Monascus fermented products with a function that reduces body fatness formation and the method for manufacturing the same
TWI415619B (en) 2011-08-02 2013-11-21 Sunway Biotech Co Ltd Composition for lowering blood lipid and elevating high-density lipoprotein and a method for manufacturing the same
CN103432387B (en) * 2013-08-20 2016-09-28 冯子龙 The Chinese herbal medicament oral liquid for the treatment of diabetes and production technology thereof

Also Published As

Publication number Publication date
US20170135983A1 (en) 2017-05-18
AU2016225884A1 (en) 2017-06-01
TWI643616B (en) 2018-12-11
CA2939456A1 (en) 2017-05-13
US20180338949A1 (en) 2018-11-29
KR20170056419A (en) 2017-05-23
JP2017088593A (en) 2017-05-25
US10143678B1 (en) 2018-12-04
TW201716062A (en) 2017-05-16
EP3167894A1 (en) 2017-05-17

Similar Documents

Publication Publication Date Title
IL259123B (en) Two-part compositions for application over skin
SG11201705093UA (en) Composition for treating il-6-related diseases
SG10201913800UA (en) Patient interfaces
IL258997B (en) Honey-cannabinoid therapeutic composition
EP3302439A4 (en) Therapeutic composition
ZA201607842B (en) Sugar replacement composition
RS58971B1 (en) Composition for ocular health
SG11201705194XA (en) Pharmaceutical composition for treating diabetes
EP3262948A4 (en) Powdered fat composition for chocolate
EP3491153A4 (en) Sugar composition
SG11201707117SA (en) Ophthalmic composition
EP3305085A4 (en) Chocolate
IL258277B (en) Liquid pesticidal composition
HK1254371A1 (en) Viscoelastic composition
HK1250491A1 (en) Stabilized pharmaceutical composition
GB201519326D0 (en) Composition`
GB201602626D0 (en) Glycemic reducing composition
EP3369419A4 (en) Composition for treating diabetes
HK1246092A1 (en) Composition for chocolate drink
ZA201800752B (en) Improved prosthesis for osteosynthesis
SG10201606939WA (en) Composition for regulating blood sugar
GB201520003D0 (en) Snowboard
GB201513543D0 (en) Compositions for use in the treatment of diabetes
PL3145317T3 (en) Fat composition
AU2016902954A0 (en) Sugar composition